Naturally Presented Peptides on Major Histocompatibility Complex I and II Molecules Eluted from Central Nervous System of Multiple Sclerosis Patients
Open Access
- 1 September 2009
- journal article
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 8 (9) , 2090-2101
- https://doi.org/10.1074/mcp.m900001-mcp200
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNSBrain, Behavior, and Immunity, 2008
- Identification of HLA-DR–bound peptides presented by human bronchoalveolar lavage cells in sarcoidosisJournal of Clinical Investigation, 2007
- Neurofascin as a novel target for autoantibody-mediated axonal injuryThe Journal of Experimental Medicine, 2007
- HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple SclerosisPLOS ONE, 2007
- A second major histocompatibility complex susceptibility locus for multiple sclerosisAnnals of Neurology, 2007
- Persistent endothelial abnormalities and blood–brain barrier leak in primary and secondary progressive multiple sclerosisNeuropathology and Applied Neurobiology, 2007
- Upregulation of α-synuclein in neurons and glia in inflammatory demyelinating diseaseMolecular and Cellular Neuroscience, 2006
- Rottlerin, an inhibitor of protein kinase Cδ (PKCδ), inhibits astrocytic glutamate transport activity and reduces GLAST immunoreactivity by a mechanism that appears to be PKCδ‐independentJournal of Neurochemistry, 2003
- Frequencies of the G-protein β3 subunit C825T polymorphism and the δ 32 mutation of the chemokine receptor-5 in patients with multiple sclerosisNeuroscience Letters, 2002
- Expression of QKI Proteins and MAP1B Identifies Actively Myelinating Oligodendrocytes in Adult Rat BrainMolecular and Cellular Neuroscience, 2001